NIAID Site Search

On this World Photo Day, we explore colorized microscopy images with NIAID microscopist John Bernbaum and visual specialist Julie Marquardt.

Published: August 18, 2023

The primary objective is to assess the effect of pre-transplant (Tx) Triplex vaccination on duration of Cytomegalovirus (CMV) antiviral therapy (AVT) within the first 100 days post-Tx in CMV seropositive donor (D+) and seronegative (R-) (D+R-) liver transplant recipients (LTxRs).

The objective of this study is to better understand the needs of people living with HIV (PLWH) with post-traumatic stress disorder (PTSD), learning whether PLWH with PTSD find this treatment acceptable and helpful, and to begin to understand the relationship between HIV-related health factors (e.g., inflammation and stress biology) and PTSD, and how these health factors may improve during treatment.

Images not listed below are believed to be in the public domain. Cover: National Library of Medicine (NLM), National Institutes of Health (NIH), B016393 Page 4: Figure 1.A. Courtesy of the Kinyoun Family Archives private document collection Page 4: Figure 1.C. Courtesy of the Kinyoun Family Archives private document collection Page 4: Figure 1.D. Courtesy of the Kinyoun Family Archives private

Last Reviewed: August 28, 2012

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. The trial aims to understand if different vaccine regimens—prototype and variant vaccines alone and in combinations—can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot. The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Published: March 31, 2022

To protect people against Coccidioides infection, the NIAID Strategic Plan for Research to Develop a Valley Fever Vaccine reflects the NIAID research priorities for developing a Valley fever vaccine.

Last Reviewed: May 1, 2025

NIAID-supported investigators are researching schistosomiasis in countries where the disease is common.

Last Reviewed: January 30, 2020

Jennifer M Ross, Ph.D., of the University of Washington K01 sample application

Last Reviewed: March 31, 2025

Scientists at NIAID developed a new tool to help identify geographic hot spots for Aedes mosquitoes, a type of mosquito that can spread diseases such as dengue, Zika and chikungunya. The tool uses a marker from blood serum to identify people bitten by Aedes mosquitoes. Monitoring for this marker in blood samples could help find sites where disease-carrying mosquitoes live, allowing for targeted interventions against dengue and other diseases.

Published: May 1, 2024

GVIRF 2023 GVIRF 2023 Agenda GVIRF 2023 Presentations GVIRF 2021 GVIRF 2021 Agenda GVIRF 2021 Presentations GVIRF Publications (2014-2021) GVIRF 2021 Publication GVIRF 2018 Publication GVIRF 2016 Publication GVIRF 2014 Publication

Last Reviewed: October 5, 2023

Immunology Interest Group (IIG) Newsletter May 2024

Last Reviewed: October 2, 2024

NIAID Safety Reporting and Pharmacovigilance for microbiology and infectious diseases clinical research

Last Reviewed: November 19, 2024

Tell us about your role at NIAID and what a typical day at work looks like for you? I am a presidential management fellow (PMF) assigned to NIAID. In this role, I spend two years rotating throughout NIAID in various offices that match my interests. My broad professional interest is in pandemic preparedness and response. Because I rotate offices every three months my typical workday changes—one

Last Reviewed: March 13, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: February 9, 2024

Study the epidemiology of viral HIV suppression and determine study approaches or evidence-based digital treatment interventions to reduce HIV transmission in Mexico and South and Central America.

Published: May 1, 2024

Lead Institution: Johns Hopkins University Research Areas The overall goals of the Southern Africa ICEMR are to study barriers to malaria control and elimination and inform national strategies. The Southern Africa ICEMR addresses these challenges in low, moderate, and high transmission settings in Zambia. In the low transmission setting in southern Zambia, ICEMR researchers study how malaria

Last Reviewed: July 12, 2024

NIAID Expert Panel provided addendum guidelines for the prevention of peanut allergy in the United States.

Last Reviewed: January 19, 2017

A NIAID-supported Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic COVID-19 in adults has begun.

Published: July 27, 2020

Last Reviewed: March 28, 2024

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022